this is a translation, and I can't say much for the source.. but i'm sure you can find other bits of info via google
from finance.jrj.com.cn/biz/2011/03/2717339573944.shtml
Xu Wei: SiBiono main domestic listing next year, again with hope that the big European market today
Xu Wei: SiBiono main domestic listing next year, again with hope that the big European market today
At 17:33 on March 27, 2011 Source: Finance site ?Font: Big in Small ? User Reviews
After a financial Web site shares information crisis, the race seems a hundred Nokia Technology Co., Ltd. because of disappeared from public view. Today, in 2011 the tenth business women business leaders in China figures , female figures ceremony, cutting-edge, game for a hundred Nokia Technology Co., Ltd. (hereinafter referred to SiBiono) as the winner, President Xu Wei attended, and financial dialogue she said, the current operation SiBiono has been on the right track, is actively preparing for listing, the company will have three each in the capital market to market, the company SiBiono master plan in the country to do the GEM or the SME board, Many VCs have expressed willingness to cooperate.
Search for news on SiBiono, mostly stay in that part of the "entrepreneurial, innovative scientists tragicomedy" During a storm on the options. Xu Wei said the company has experienced turbulence, the process of innovation and development, there are some problems, basically have been resolved, in many cases is not able to complete understanding of the outside world, the company is now on the right track, and gradually digested a number of issues before the wind rain rain is normal.
Patent for Gendicine, she said Gendicine is SiBiono is certain, both from occupational or vocational areas and inventions are. "Innovation is not concerned about the name of the initial problem, which is experiencing the throes of drug innovation," going through the development of future reference, Xu Wei's attitude is very open-minded.
She pointed out that innovation SiBiono problems some more, involve a number of foreign genes have possession of the strategic aims, we know only the tip of the iceberg. National policy in this area has been under protection of the enterprise will be better. Wei Xu acknowledged that foreign misappropriation of plunder, from a lot of them can not read them with a strong China, foreign M & A business owned by the Ministry of Commerce checks, especially those related to core technology, can avoid some of the innovative enterprises in the very developed under the difficult circumstances the results of lost in vain. She also said that the Human Genome Project in China account for only 1% of the share, while the share of gene therapy to 100% of stations, gene therapy, the crowd, basically in China, the leading of the building was not easy.
Xu Wei: SiBiono main domestic listing next year, again with hope that the big European market today
At 17:33 on March 27, 2011 Source: Finance site ?Font: Big in Small ? ????
Listing of three parts
Xu Wei said the company had also not in dispute when the case of bankruptcy. People did not do business loans do not know, was a little debt, some people might have that idea. Now some of the debts before the clean-up, in fact, debt is normal, not horrible.
Xu Wei said that the loans are also out now, the company development strategy in order to absorb some of the wind to vote, go to the capital markets, SiBiono to expand the indications need to do a lot of research costs. Therefore, the listing SiBiono very clear plan in the country to do the GEM or the SME board, a lot of venture capital in the concern also extended the industrial chain, the company will have three each in the capital market to market.
For the specific point in time, she said, quickly listing will advance because patterns are mature, the construction of expert resources is very high, this is also the main SiBiono prepare, because the main need to clean this time, the specific time to market can not be sure, the domestic market next year, hope great.
In Europe there, now and hygiene products to be registered in the EU market, raising funds in the European Union by SiBiono holding.
Meanwhile, in Beijing, Shanghai, Guangzhou, Zhejiang and other places the construction of gene therapy center management company, extends to health care, and major hospitals to high-end cancer gene therapy center. Ordered this year for venture capital to build the underground center, convenient to treat a large number of foreign patients.
Shenzhen is the origin for the same neighbor Haipu Rui (002 399) was sensational effect after the listing, Xu Wei said she was listed SiBiono full of hope and expectation, to the Hai Purui learning, ask.
Xu Wei: SiBiono main domestic listing next year, again with hope that the big European market today
At 17:33 on March 27, 2011 Source: Finance site ?Font: Big in Small ? User Reviews
Failure rate of 90% bio-medicine center to settle down
Some people say money is not suitable for innovation in China, many people look at the stock market and real estate industry alone to do it? Xu Wei on the issue given a warm response, she said, must overcome the excessive pursuit of profits to capital markets, the mentality, not lose the spirit of entrepreneurs, to get down to do a good job. She admires the German model of entrepreneurs, the U.S. lost the industry, over the pursuit of capital, is the root of the crisis.
Xu Wei said that China needs a creative mind very much, not only for the money, the money for the past three years to scale, lack of funds is not so, now sinking heart, biological medicine 90% failure rate, not a good state of mind can not choose to do a good job a lot of foundation work, to do science, we can not simply pursue the concept of wealth, so terrible.
Need to first put a lot of time doing charity when their first pay, dedication, before harvest, so as to overcome the difficulties. The pharmaceutical industry and the Internet, not the same curve of development of enterprises, to long-term scientific development.
News 
Market Data 
Discover 
